Johnson & Johnson Statement on U.S. Government Donations of Company ’s COVID-19 Vaccine

NEW BRUNSWICK, N.J., July 9, 2021 – Johnson & Johnson welcomes the U.S. government’s decision to donate an initial 12 million doses of the Company’s COVID-19 vaccine through the COVAX Facility. The United States is sharing the doses via COVAX to multiple lower-income countries across three continents. The first shipment of 1.5 million doses arrived in Afghanistan on July 9, 2021. In the coming weeks, it is anticipated that the U.S. will allocate a second tranche of Johnson & Johnson COVID-19 vaccines to additional lower-income countries. Separately, the U.S. has already donated 8 million doses of the Company’s vaccine via a series of bilateral agreements with higher-income countries including Brazil, Colombia, Mexico and South Korea. “Equitable global access is at the forefront of Johnson & Johnson’s COVID-19 response. We strongly support the leadership shown by the Biden-Harris Administration in ensuring lifesaving COVID-19 vaccines can be redirected to where public health needs are most pressing,” said Paul Stoffels, M.D., Chief Scientific Officer and Vice Chairman of the Executive Committee, Johnson & Johnson. “We believe that a single-shot, easy to distribute COVID-19 vaccine is an essential tool to combat the pandemic globally.”The dose donations to COVAX were enabled by a tripartite agreement signed recently by the U.S. government, Johnson & Johnson and Gavi, the Vaccine Alliance. All recipient countries were designated by the U.S. ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news